Search Results - "Rapoport, S I"

Refine Results
  1. 1

    Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients by Rao, J S, Harry, G J, Rapoport, S I, Kim, H W

    Published in Molecular psychiatry (01-04-2010)
    “…Reports of cognitive decline, symptom worsening and brain atrophy in bipolar disorder (BD) suggest that the disease progresses over time. The worsening…”
    Get full text
    Journal Article
  2. 2

    Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients by Rao, J S, Keleshian, V L, Klein, S, Rapoport, S I

    Published in Translational psychiatry (03-07-2012)
    “…Alzheimer's disease (AD) and bipolar disorder (BD) are progressive brain disorders. Upregulated mRNA and protein levels of neuroinflammatory and arachidonic…”
    Get full text
    Journal Article
  3. 3

    n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism by RAO, J. S, ERTLEY, R. N, LEE, H.-J, DEMAR, J. C, ARNOLD, J. T, RAPOPORT, S. I, BAZINET, R. P

    Published in Molecular psychiatry (01-01-2007)
    “…Decreased docosahexaenoic acid (DHA) and brain-derived neurotrophic factor (BDNF) have been implicated in bipolar disorder. It also has been reported that…”
    Get full text
    Journal Article
  4. 4

    Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? by Rao, J S, Lee, H-J, Rapoport, S I, Bazinet, R P

    Published in Molecular psychiatry (01-06-2008)
    “…Bipolar disorder is a major medical, social and economic burden worldwide. However, the mechanisms of action of effective antibipolar disorder drugs remain…”
    Get full text
    Journal Article
  5. 5

    Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients by Kim, H-W, Rapoport, S I, Rao, J S

    Published in Molecular psychiatry (01-04-2011)
    “…Mood stabilizers that are approved for treating bipolar disorder (BD), when given chronically to rats, decrease expression of markers of the brain arachidonic…”
    Get full text
    Journal Article
  6. 6

    Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex by RAO, J. S, ERTLEY, R. N, DEMAR, J. C, RAPOPORT, S. I, BAZINET, R. P, LEE, H.-J

    Published in Molecular psychiatry (01-02-2007)
    “…The enzymes that regulate the brain arachidonic acid (AA) cascade have been implicated in bipolar disorder and neuroinflammation. Fifteen weeks of dietary n-3…”
    Get full text
    Journal Article
  7. 7

    Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain by BOSETTI, F, RINTALA, J, SEEMANN, R, ROSENBERGER, T. A, CONTRERAS, M. A, RAPOPORT, S. I, CHANA, M. C

    Published in Molecular psychiatry (01-09-2002)
    “…Rats treated with lithium chloride for 6 weeks have been reported to demonstrate reduced turnover of arachidonic acid (AA) in brain phospholipids, and…”
    Get full text
    Journal Article
  8. 8

    The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults by DECARLI, C, MURPHY, D. G. M, SCHAPIRO, M. B, TRANH, M, GRADY, C. L, HAXBY, J. V, GILLETTE, J. A, SALERNO, J. A, GONZALES-AVILES, A, HORWITZ, B, RAPOPORT, S. I

    Published in Neurology (01-11-1995)
    “…To assess the association of MRI white matter hyperintensities (WMHI) with cognitive performance, cerebral structure, and cerebral metabolism in 51 healthy…”
    Get full text
    Journal Article
  9. 9

    Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease by IBANEZ, V, PIETRINI, P, ALEXANDER, G. E, FUREY, M. L, TEICHBERG, D, RAJAPAKSE, J. C, RAPOPORT, S. I, SCHAPIRO, M. B, HORWITZ, B

    Published in Neurology (01-06-1998)
    “…To determine whether the hypometabolism observed in PET images of patients with Alzheimer's disease (AD) is due entirely to brain atrophy. Reduced brain…”
    Get full text
    Journal Article
  10. 10

    Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy by Rapoport, S I

    Published in Expert opinion on investigational drugs (01-10-2001)
    “…The blood-brain barrier (BBB) to water-soluble drugs and macromolecules can be opened in vivo by infusing a hypertonic solution of arabinose or mannitol into…”
    Get more information
    Journal Article
  11. 11

    Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder? by Lee, H-J, Rao, J S, Chang, L, Rapoport, S I, Kim, H-W

    Published in Molecular psychiatry (01-06-2010)
    “…Agents effective against mania in bipolar disorder are reported to decrease turnover of arachidonic acid (AA) in phospholipids and expression of…”
    Get full text
    Journal Article
  12. 12

    Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome by Siarey, R.J., Stoll, J., Rapoport, S.I., Galdzicki, Z.

    Published in Neuropharmacology (01-11-1997)
    “…We investigated the phenomenon of long-term potentiation (LTP) in a genetic model of Down Syndrome, the segmental trisomy mouse (Ts65Dn). Ts65Dn mice survive…”
    Get full text
    Journal Article
  13. 13

    Is phosphoadenosine phosphate phosphatase a target of lithium’s therapeutic effect? by Shaltiel, G., Deutsch, J., Rapoport, S. I., Basselin, M., Belmaker, R. H., Agam, G.

    Published in Journal of Neural Transmission (01-11-2009)
    “…Lithium, which is approved for treating patients with bipolar disorder, is reported to inhibit 3′(2′)-phosphoadenosine-5′-phosphate (PAP) phosphatase activity…”
    Get full text
    Journal Article
  14. 14

    Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer’s disease in relation to dementia severity: evidence for early neocortical degeneration by Teipel, S.J, Bayer, W, Alexander, G.E, Bokde, A.L.W, Zebuhr, Y, Teichberg, D, Müller-Spahn, F, Schapiro, M.B, Möller, H.-J, Rapoport, S.I, Hampel, H

    Published in Neurobiology of aging (01-01-2003)
    “…We used volumetric MRI and analysis of areas under receiver operating characteristic (ROC) curves to directly compare the extent of hippocampus–amygdala…”
    Get full text
    Journal Article
  15. 15

    Network analysis of cortical visual pathways mapped with PET by McIntosh, AR, Grady, CL, Ungerleider, LG, Haxby, JV, Rapoport, SI, Horwitz, B

    Published in The Journal of neuroscience (01-02-1994)
    “…Brain metabolic mapping techniques, such as positron emission tomography (PET), can provide information about the functional interactions within entire neural…”
    Get full text
    Journal Article
  16. 16

    Face Encoding and Recognition in the Human Brain by Haxby, James V., Ungerleider, Leslie G., Horwitz, Barry, Jose Ma. Maisog, Rapoport, Stanley I., Grady, Cheryl L.

    “…A dissociation between human neural systems that participate in the encoding and later recognition of new memories for faces was demonstrated by measuring…”
    Get full text
    Journal Article
  17. 17

    Cholinergic Stimulation Alters Performance and Task-Specific Regional Cerebral Blood Flow During Working Memory by Furey, M. L., Pietrini, P., Haxby, J. V., Alexander, G. E., Lee, H. C., VanMeter, J., Grady, C. L., Shetty, U., Rapoport, S. I., Schapiro, M. B., Freo, U.

    “…Modulation of the cholinergic neurotransmitter system results in changes in memory performance, including working memory (WM), in animals and in patients with…”
    Get full text
    Journal Article
  18. 18

    Dissociation of Object and Spatial Visual Processing Pathways in Human Extrastriate Cortex by Haxby, James V., Grady, Cheryl L., Horwitz, Barry, Ungerleider, Leslie G., Mishkin, Mortimer, Carson, Richard E., Herscovitch, Peter, Schapiro, Mark B., Rapoport, Stanley I.

    “…The existence and neuroanatomical locations of separate extrastriate visual pathways for object recognition and spatial localization were investigated in…”
    Get full text
    Journal Article
  19. 19

    Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome by Siarey, Richard J, Carlson, Elaine J, Epstein, Charles J, Balbo, Andrea, Rapoport, Stanley I, Galdzicki, Zygmunt

    Published in Neuropharmacology (01-12-1999)
    “…Long-term potentiation (LTP) and depression (LTD) were investigated in hippocampus of a genetic model of Down syndrome, the segmental trisomy (Ts65Dn) mouse…”
    Get full text
    Journal Article
  20. 20

    Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer’s disease brain by Rao, J S, Rapoport, S I, Kim, H-W

    Published in Translational psychiatry (16-08-2011)
    “…Alzheimer’s disease (AD), a progressive neurodegenerative disorder, is the leading cause of dementia in the elderly. A recent positron emission tomography…”
    Get full text
    Journal Article